作者:
Ichhpujani,P. [1]
;
Katz,L.J. [2]
;
Hollo,G. [3]
;
Shields,C.L. [4]
;
Shields,J.A. [5]
;
Marr,B. [6]
;
Eagle,R. ;
Alvim,H. ;
Wizov,S.S. ;
Acheampong,A. ;
Chen,J. ;
Wheeler,L.A.
作者单位:
Department of Ophthalmology, Semmelweis University, Budapest, Hungary
[1]
Department of Safety Evaluation, Allergan, Inc., Irvine, CA, United States
[2]
Oncology Service, Willis Eye Institute, Philadelphia, PA, United States
[3]
Department of Biological Sciences, Allergan, Inc., Irvine, CA, United States
[4]
Department of Pathology, Willis Eye Institute, Philadelphia, PA, United States
[5]
Anne V. Goldberg Glaucoma Service, Willis Eye Institute, Philadelphia, PA, United States
[6]
发布时间
2013-11-20